According to Grifols's latest financial reports the company's current revenue (TTM) is $6.84 B. In 2020 the company made a revenue of $6.18 B an increase over the years 2019 revenue that were of $5.70 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2023 (TTM) | $6.84 B | |
2020 | $6.18 B | 8.46% |
2019 | $5.70 B | 8.23% |
2018 | $5.26 B | 6.21% |
2017 | $4.95 B | 10.96% |
2016 | $4.46 B | 2.69% |
2015 | $4.35 B | -0.44% |
2014 | $4.37 B | 20.07% |
2013 | $3.64 B | 6.74% |
2012 | $3.41 B | 39.25% |
2011 | $2.44 B |
Company | Revenue | Revenue differencediff. | Country |
---|---|---|---|
Johnson & Johnson JNJ | $93.02 B | 1,259.02% | ๐บ๐ธ USA |
Amgen AMGN | $28.19 B | 311.85% | ๐บ๐ธ USA |
Baxter BAX | $14.94 B | 118.40% | ๐บ๐ธ USA |
Kimberly-Clark KMB | $20.43 B | 198.49% | ๐บ๐ธ USA |